CD276 and glioblastoma: Furthermore, our results demonstrate a significant correlation between HOXB9 expression and CD276 expression in several cancers, including BLCA, CESC, COAD, GBM, KIRC, KIRP, LAML, LGG, LIHC, LUSC, MESO, OV, PCPG, TGCT, and UVM.